Abeona Therapeutics Inc.

ABEONASDAQHealthcare● Active

$5.38

$-0.08(-1.47%)

Market Cap$306633875

P/E Ratio—

52W High$7.54

52W Low$4

Avg Volume1.2M

Open$5.51

Beta1.35

Overview

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Abeona Therapeutics Inc. (ABEO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ABEO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$1.28Earnings history

PE Ratio (TTM)4.2×PE Ratio deep dive

Revenue (TTM)$14.5MFull revenue history

Dividend Yield8.55%Dividend history

Shares Outstanding53.0MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

Explore Abeona Therapeutics Inc. Data

Market Cap$306.6M

Analyst Forecast$17 · Buy

Dividends8.55%

Revenue$5.8M

EarningsEPS $1.34+186.45%

PE Ratio4.2×

Financial Snapshot

Full Financials

FY 2025Revenue$5.8M

202320242025

FY 2025Net Income$71.2M▲ +211.69% YoY

202320242025

FY 2025EPS$1.34▲ +186.45% YoY

202320242025

TTM:Revenue: $14.5MNet Income: $66.1MEPS: $1.28View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy9 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$17.00Low

$5.38Current

$17.00Avg Target215.99% upside

$17.00High

Total: 9 · Buy rate: 66.7%

The ABEO analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +215.99% upside from the current price of $5.38.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

ABEO

Abeona Therapeutics Inc.

$5.38-1.47%$306.6M #2

ARCT

Arcturus Therapeutics Holdings Inc.

$7.12-2.47%$202.4M #3

ASMB

Assembly Biosciences, Inc.

$22.56-1.51%$358.5M #4

ELDN

Eledon Pharmaceuticals, Inc.

$3.58+4.99%$214.6M #5

FHTX

Foghorn Therapeutics Inc.

$3.71-0.54%$217.8M #6

HUMA

Humacyte, Inc.

$1.38+2.22%$231.8M

Stock Performance

Full History

1D-1.47%

1W-5.11%

1M-8.81%

3M+10.93%

YTD+2.09%

1Y-17.74%

5Y-87.98%

About Abeona Therapeutics Inc.

CEOVishwas Seshadri

IPO DateSep 19, 1980

Employees136

CountryUS

Websiteabeonatherapeutics.com

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its l…

Biotechnology HealthcareNASDAQUS

About Stock Overview & Key Data

Abeona Therapeutics Inc. (ABEO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 19, 1980. As of the latest trading session, ABEO stock price is $5.38, with a market capitalization of $306.6M. The stock has returned -17.74% over the past 12 months and +2.09% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Abeona Therapeutics Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Abeona Therapeutics Inc. reported revenue of $5.8M and net income of $71.2M. For detailed data — including Abeona Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Abeona Therapeutics Inc. (ABEO) stock price is $5.38. The stock is traded on NASDAQ under the ticker symbol ABEO. The 52-week range is $4.00 – $7.54.

ABEO stock priceABEO quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice